Serum GDF15 levels are significantly higher in patients with HCC and cirrhosis than in healthy controls, and their combination with α-fetoprotein (AFP) improves diagnostic accuracy [107]. This evidence concerns the gene GDF15 and hepatocellular carcinoma.